Blood-Borne Diseases

The FDA grants PMA approval for the Aptima HBV Quant Assay for the quantitation of hepatitis B viral load on the Panther system.

The San Diego Board of Supervisors ends the local public health emergency announced in September 2017 for the ongoing hepatitis A outbreak in San Diego.

The opioid epidemic in the United States has led to a sharp increase in hepatitis C cases, and with that, a rise in hospitalizations according to a new report.

A new study confirms the ribavirin steady-state serum levels that correspond to high rates of efficacy and low adverse events.

Health officials across the United States have their hands full as hepatitis A cases continue to spring up.

Leonard Sigal, MD, explains the potential adverse consequences of long-term antibiotic therapy.

We’ve rounded up the 10 biggest infectious disease outbreaks of 2017.

Herewith, 4 New Year’s resolutions for the infectious disease community—at least according to us here on the Public Health Watch.

The American Society of Transplantation has reached a consensus on how the treatment of hepatitis C virus with direct-acting antivirals could enable organ transplantations to HCV-negative recipients.

Forty years after the first Ebola outbreak in the Democratic Republic of Congo, investigators find that a small group of survivors are still producing virus-fighting antibodies.

The results of a new study show that when a best practice advisory (BPA) displayed in the electronic health record of patients in the baby boomer generation, it prompted a 5-fold increase in screening for hepatitis C virus (HCV) in this population.

Hepatitis C is more curable than ever thanks to direct-acting antivirals, and now, a new study shows how expanded access to these drugs through Medicaid is helping more individuals get treated.

Five outbreaks of hepatitis A continue to beat down on several states; can addressing the homelessness crisis prevent future outbreaks from happening?

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A new study examines HCV treatment uptake in HCV patients coinfected with HIV.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Hepatitis A outbreaks have been ravaging 5 US states, leaving health officials scrambling.

A recent study finds that prolonged infusion of antipseudomonal β-lactams in patients with sepsis was associated with significantly less mortality when compared with short-term infusion.

The results of a new study show that patients who are co-infected with the hepatitis C virus (HCV) and HIV can experience cure rates similar to individuals infected with HCV alone when both groups receive direct-acting antiviral drugs.

World Toilet Day, November 9th, is dedicated to promoting awareness and inspiring action against the global sanitation crisis.

A research team has found that an antiviral drug available in Russia and a few other countries shows promising results when it comes to fighting Ebola virus disease.

Researchers are gaining a greater understanding of the role that human genetics plays in determining who contracts tuberculosis as well as how severely it impacts its victims.

As the hepatitis A outbreak in San Diego continues, officials focus their efforts on homeless encamped along the San Diego River. Is the situation improving or getting worse?

The vaccine is the only 2-dose regimen for the prevention of infection by all known subtypes of hepatitis b in adults 18 and older.

Despite the availability of highly active agents against HCV, HIV-infected patients require special considerations for drug interactions when considering treatment options.